BiotechTube
DINAMIQS

DINAMIQS

Zurich, Switzerland· Est.
dinamiqs.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.2M

Overview

DINAMIQS is a private, Zurich-based CDMO providing viral vector manufacturing services to the cell and gene therapy sector. The company has built a leadership team with deep scientific and operational expertise and recently opened a new cGMP facility to support client programs. Its business model is service-based, generating revenue through contracts, and it is actively expanding its capabilities and commercial reach, as evidenced by recent leadership hires and technology acquisitions.

Digital HealthAI / Machine Learning

Technology Platform

End-to-end viral vector (AAV, Lentivirus) CDMO platform with integrated process/analytical development, cGMP manufacturing, and quality services. Utilizes acquired high-yield HEKExpress® cell line technologies and emphasizes early molecule design and robust scale-up.

Funding History

1
Total raised:$3.2M
Seed$3.2M

Opportunities

The company is positioned in the high-growth cell and gene therapy CDMO market, where a shortage of reliable viral vector manufacturing capacity creates strong demand.
Recent expansion of its cGMP facility and acquisition of high-yield cell line technology provide tangible advantages to capture this demand and support clients from clinical to commercial stages.

Risk Factors

Key risks include intense competition from larger, established CDMOs, operational risks associated with flawless cGMP execution and scale-up, and dependency on the overall health and funding of the biotech and gene therapy sector, which can be cyclical.

Competitive Landscape

DINAMIQS competes in a crowded viral vector CDMO space against large players like Lonza and Catalent, as well as specialized firms like Oxford Biomedica, Thermo Fisher's Brammer Bio, and Ascend Advanced Therapies. It differentiates through a strong scientific focus, Swiss quality reputation, and targeted technology like the HEKExpress cell lines.

More companies in Switzerland →